SPOTLIGHT -
Any T cell-mediated disease found to benefit from this therapy without affecting other inflammatory pathways
Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine
EyePod: Transforming the MIGS pipeline into clinical reality
Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform
EyePod: Week in Review - September 17, 2023
ProQR Therapeutics offers update on sale of ophthalmic assets
FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis